T-细胞可诱导共刺激分子(ICOS)重组蛋白

Recombinant Inducible T-Cell Co Stimulator (ICOS)

CD278; AILIM; Inducible T-Cell Costimulator; Activation-Inducible Lymphocyte Immunomediatory Molecule

  • T-细胞可诱导共刺激分子(ICOS)重组蛋白产品包装(模拟)
  • T-细胞可诱导共刺激分子(ICOS)重组蛋白产品包装(模拟)
  • RPA777Hu01.jpgFigure. SDS-PAGE
  • Certificate通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

参考文献

杂志参考文献
Archives of Dermatological ResearchIncreased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis[Pubmed: 23053221]
DNA Cell Biol. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration.[Pubmed: 24083358]
RheumatologyAugmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis[Pubmed: 23024058]
Br J HaematolInducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment[Pubmed:34954822]
Diagnostics (Basel)Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases[Pubmed:35328257]